ESC 365 - Prevalence of cardiovascular comorbidities among hospitalized patients with hypertrophic cardiomyopathy and factors associated with a higher case-fatality rate

ESC Professional Premium Access

Prevalence of cardiovascular comorbidities among hospitalized patients with hypertrophic cardiomyopathy and factors associated with a higher case-fatality rate

Session: Novel insights into Brugada syndrome and hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor S. Shoar (Largo, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Saeed Shoar

University of Maryland Capital Region Medical Center, Largo (United States of America)

0 follower

7 more presentations in this session

Relationship between epicardial adipose tissue and ventricular fibrillation in Brugada syndrome by cardiac computed tomography analysis

Speaker: Mr K. Yonezu (Yufu City, JP)

Prognostic parameters predict cardiac events in Brugada syndrome: a meta-analysis

Speaker: Mr P. Pajareya (Bangkok, TH)

Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes

Speaker: Doctor C. Mann (Vienna, AT)

Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy

Speaker: Professor J. Choi (Seoul, KR)

Nationwide trends in utilization and safety of ventricular arrythmia ablation in patients with hypertrophic cardiomyopathy

Speaker: Doctor G. Rozen (Boston, US)

Access the full session

Novel insights into Brugada syndrome and hypertrophic cardiomyopathy

Speakers: Doctor S. Shoar, Mr K. Yonezu, Mr P. Pajareya, Doctor C. Mann, Professor J. Choi...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources